TEN13
VC Fund
Brisbane, Australia
TEN13 is a world-leading syndicated platform based in Australia. Founded by Steve Baxter and Stew Glynn.
- Total investments:
- 91
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries TEN13 invests in
Stages TEN13 invests in
Countries TEN13 invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 6 contacts → | |||
Round size
- Seed
- $999k–$8M
- Pre-Seed
- $877k–$2M
- Series A
- $4M–$46M
Investment Focus
Industry
- Software 16 (18%)
- SaaS 9 (10%)
- FinTech 8 (9%)
- Financial Services 8 (9%)
- Artificial Intelligence 8 (9%)
Stage
- Seed 37 (41%)
- Series A 20 (22%)
- Pre-Seed 12 (13%)
- Venture - Series Unknown 4 (4%)
- Series B 3 (3%)
Country
- Australia 33 (36%)
- United States 14 (15%)
- Kenya 2 (2%)
- Nigeria 2 (2%)
- New Zealand 2 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Bob Waldie
Private Investor
|
Private Investor | Total investments: 0 | Find email | |
Michael Koukourou
Angel Investor
|
Angel Investor | Total investments: 0 | Find email | |
Rick Stevenson
Private Investor
|
Private Investor | Total investments: 0 | Find email | |
Stephen Baxter
Partner
|
Partner | Total investments: 8 | Find email | |
Stephen Baxter
Partner
|
Partner | Total investments: 38 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Pearler
|
Pearler is an investing app that helps people achieve their financial goals by connecting them to a supportive community. Its goal is to assist ordinary people in becoming successful long-term investors. The company was established in 2018 in Sydney, New South Wales, Australia. | $11.4M / Series A / Sep 02, 2026 | |
Arintra
|
Arintra provides an AI-powered autonomous medical coding platform to streamline hospital and clinic revenue cycle management. The platform processes clinical documentation to generate accurate diagnostic and procedural codes (e.g., ICD‑10, CPT) within electronic health records like Epic or Cerner, requiring zero manual input. It offers explainableaudit trails and analytics dashboards that track coding accuracy, denial trends, and workflow efficiency. Clients report measurable improvements such as a 5% increase in revenue and over 50% reduction in aged accounts receivable days following implementation. | $25M / Series B / Aug 21, 2026 | |
bowerlabs.ai
|
Bower develops software and wearable hardware for documenting and supporting scientific laboratory work. Its Bower Workspace combines capture and record functions for collecting voice notes, images, videos, text, configurations, and experimental data. The platform organizes these inputs into searchable records for laboratory teams. Bird is anintegrated AI assistant that uses workspace notes and web-based scientific information to answer questions, summarize findings, compare experiments, and provide citations. Bower Smart Glasses provide hands-free procedure guidance and documentation support at the laboratory bench. The products support research documentation, collaboration, protocol execution, and transfer of technical knowledge. | $1.4M / Pre-Seed / Aug 19, 2026 | |
Vexev
|
Vexev is on a mission to introduce innovative imaging diagnostic tools. | $6M / Venture - Series Unknown / Aug 06, 2026 | |
Flyweel
|
Flyweel is agentic fintech for businesses that depend on ads for their growth. It connects spend, cash, and revenue, then acts on them in real time, shifting budget to the ads that work, drawing capital when the numbers justify it, and easing off when cash runs low, all without anyone in the loop. | $1.7M / Pre-Seed / Jun 01, 2026 | |
Appetise
|
Appetise is a cloud-based food technology platform with sustainable meal kit delivery providers. | $4.9M / Series A / Feb 19, 2026 | |
AutoGrab
|
AutoGrab is a vehicle software company that is focused on assisting dealerships, finance and insurance companies. | $55.3M / Series B / Jan 27, 2026 | |
Atrium
|
Atrium is a personal chief of staff platform driven by artificial intelligence. | $1.3M / Pre-Seed / Dec 16, 2025 | |
OneMRI
|
OneMRI is a provider of comprehensive whole-body MRI scans that are radiation-free, clinically reviewed by radiologists, and explained by doctors. | $1.6M / Seed / Aug 18, 2025 | |
|
Arintra
|
Arintra provides an AI-powered autonomous medical coding platform to streamline hospital and clinic revenue cycle management. The platform processes clinical documentation to generate accurate diagnostic and procedural codes (e.g., ICD‑10, CPT) within electronic health records like Epic or Cerner, requiring zero manual input. It offers explainableaudit trails and analytics dashboards that track coding accuracy, denial trends, and workflow efficiency. Clients report measurable improvements such as a 5% increase in revenue and over 50% reduction in aged accounts receivable days following implementation. | $21M / Series A / Aug 14, 2025 | |
| See all 91 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does TEN13 invest in?
TEN13 invests primarily in Software, SaaS and FinTech startups, most often at Seed and Series A stage. Most of the 91 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is TEN13's check size?
TEN13 typically joins rounds of $999k–$8M at Seed, $877k–$2M at Pre-Seed and $4M–$46M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds TEN13 participates in.
How do I contact TEN13?
Public channels for TEN13 include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at TEN13?
The team at TEN13 includes Bob Waldie (Private Investor), Michael Koukourou (Angel Investor) and Rick Stevenson (Private Investor), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
